Answers are grounded in this paper and cite their sources.
DNA sequencing of rpoB and culture-based drug susceptibility results were evaluated for samples referred for confirmation of rifampin resistance detected by the Cepheid Xpert MTB/RIF assay. Silent mutations and mutations associated with low-level resistance were found in the study population. These data support CDC recommendations to confirm Xpert rifampin resistance results.
No takes yet. Share an insight, caveat, or question.
McAlister et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: